Cargando…
Antineoplastic drugs : organic synthesis /
"Antineoplastic Drugs: Organic Syntheses is written to appeal to organic and medicinal chemists in industry and academia. It is beneficial to those composing grant proposals for NCI and related organizations"--
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Chichester, West Sussex, United Kingdom :
John Wiley & Sons, Ltd,
2015.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn904959309 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 150408s2015 enk ob 001 0 eng | ||
| 010 | |a 2015014108 | ||
| 040 | |a DLC |b eng |e rda |e pn |c DLC |d N$T |d DG1 |d BTCTA |d IDEBK |d E7B |d CDX |d YDXCP |d COO |d EBLCP |d RECBK |d OCLCF |d OCLCQ |d DEBBG |d K6U |d COCUF |d CCO |d LIP |d PIFFA |d FVL |d ZCU |d OCLCQ |d MERUC |d OCLCQ |d U3W |d OCLCQ |d CASUM |d OCLCO |d CUY |d OCLCO |d STF |d OCLCO |d ICG |d VT2 |d OCLCQ |d UWO |d WYU |d OCLCO |d OCLCA |d MERER |d TKN |d OCLCQ |d DKC |d OCLCQ |d OCLCO |d UKAHL |d UX1 |d OCLCQ |d OCLCA |d TUHNV |d OCLCO |d OCLCQ |d OCLCO |d OCLCL | ||
| 019 | |a 905989856 |a 961695642 |a 962722672 |a 1055351597 |a 1066516092 |a 1081218198 |a 1101715658 |a 1148107921 |a 1244445103 | ||
| 020 | |a 9781118892565 |q (ePub) | ||
| 020 | |a 1118892569 |q (ePub) | ||
| 020 | |a 9781118892558 |q (Adobe PDF) | ||
| 020 | |a 1118892550 |q (Adobe PDF) | ||
| 020 | |a 9781118892572 | ||
| 020 | |a 1118892577 | ||
| 020 | |z 9781118892541 |q (cloth) | ||
| 020 | |z 1118892542 |q (cloth) | ||
| 029 | 1 | |a AU@ |b 000060217090 | |
| 029 | 1 | |a CHBIS |b 010442471 | |
| 029 | 1 | |a CHNEW |b 000944100 | |
| 029 | 1 | |a CHVBK |b 480243301 | |
| 029 | 1 | |a DEBBG |b BV042793100 | |
| 029 | 1 | |a DEBBG |b BV043397613 | |
| 029 | 1 | |a DEBBG |b BV044073521 | |
| 029 | 1 | |a DEBSZ |b 485056585 | |
| 029 | 1 | |a NZ1 |b 16078501 | |
| 035 | |a (OCoLC)904959309 |z (OCoLC)905989856 |z (OCoLC)961695642 |z (OCoLC)962722672 |z (OCoLC)1055351597 |z (OCoLC)1066516092 |z (OCoLC)1081218198 |z (OCoLC)1101715658 |z (OCoLC)1148107921 |z (OCoLC)1244445103 | ||
| 042 | |a pcc | ||
| 050 | 0 | 0 | |a RS431.A64 |
| 060 | 4 | |a QV 269 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 0 | |a 615.7/98 |2 23 |
| 084 | |a SCI007000 |2 bisacsh | ||
| 049 | |a UAMI | ||
| 100 | 1 | |a Lednicer, Daniel, |d 1929- |e author. | |
| 245 | 1 | 0 | |a Antineoplastic drugs : |b organic synthesis / |c Daniel Lednicer. |
| 264 | 1 | |a Chichester, West Sussex, United Kingdom : |b John Wiley & Sons, Ltd, |c 2015. | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a "Antineoplastic Drugs: Organic Syntheses is written to appeal to organic and medicinal chemists in industry and academia. It is beneficial to those composing grant proposals for NCI and related organizations"-- |c Provided by publisher | ||
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record and CIP data provided by publisher. | |
| 505 | 0 | |a Title Page; Copyright Page; Contents; Preface; Introduction; Chapter 1 Alkylating Agents; 1.1 bis-Chloroethyl Amines; 1.2 Several Other Chloroethyl Agents; 1.3 Platinum-Based Antineoplastic Agents; 1.4 Miscellaneous Alkylating Agents; References; Chapter 2 Antimetabolites; 2.1 Introduction; 2.2 Folate Antagonists; 2.2.1 Compounds with Glutamate Side Chain; 2.2.2 Compounds Lacking the Glutamate Moiety; 2.2.3 Methoxylated Benzenes; 2.3 Pyrimidines and Purines; 2.3.1 Aglycones; 2.3.2 Saccharide-Linked Compounds; References; Chapter 3 Hormone Blocking Anticancer Drugs; 3.1 Introduction. | |
| 505 | 8 | |a 3.2 Estrogen Antagonists; 3.2.1 Estrogen Antagonists; 3.2.2 Aromatase Inhibitors; 3.3 Androgen Antagonists; 3.3.1 Non-steroidal Antian drogens; 3.3.2 Steroid Androgen Antagonists; References; Chapter 4 Topoisomerase Inhibitors; 4.1 Introduction; 4.2 Anthracyclines; 4.3 Anthraquinones and Anthrapyrazoles; 4.3.1 Anthraquinones with Two Aminoalkyl Side Chains; 4.3.2 Anthraquinones with a Fused Pyrazole Ring; 4.3.3 Heterocyclic Anthraquinones; 4.4 Camptothecins; 4.4.1 Compounds from Modified Camptothecin; 4.4.2 Camptothecins by Total Synthesis; 4.5 Miscellaneous Topoisomerase Inhibitors; References. | |
| 505 | 8 | |a Chapter 5 Mitotic Inhibitors; 5.1 Introduction; 5.2 Taxanes; 5.3 Wholly Synthetic Compounds; 5.3.1 Carbocyclic Compounds; 5.3.2 Peptide-Like Inhibitors; 5.3.3 Monocyclic Heterocyclic Inhibitors; 5.3.4 Bicyclic 5:6 Heterocyclic Inhibitors; 5.3.5 Bicyclic 6:6 Heterocyclic Tubulin Inhibitors; References; Chapter 6 Matrix Metalloproteinase Inhibitors; 6.1 Introduction; 6.2 Hydroxamates; 6.2.1 Agents with an Isobutyl Moiety; 6.2.2 A Thiomorpholine; 6.2.3 Sulfamates; 6.2.4 Miscellaneous Compounds; References; Chapter 7 Histone Deacetylase Inhibitors; 7.1 Introduction; 7.2 Hydroxamates. | |
| 505 | 8 | |a 7.3 Phenylenediamines; References; Chapter 8 Enzyme Inhibitor, Part I, Tyrosine Kinases; 8.1 Introduction; 8.2 Epidermal Growth Factor Inhibitors; 8.3 VEGF; 8.3.1 Fused Ring Compounds; 8.3.2 Linear Arrays; 8.4 SRC Nonreceptor Tyrosine Kinase; 8.5 PDGF; 8.6 EGF; 8.7 Other TKI; 8.7.1 Linear Arrays; 8.7.2 Compounds with Two Fused Rings; 8.8 Janus Kinase Inhibitors; References; Chapter 9 Enzyme Inhibitors: Part II Additional Targets; 9.1 Serine-Threonine Kinase Inhibitors; 9.2 Additional Enzyme Inhibitors; 9.2.1 Farnesyl Transferase Inhibitors; 9.2.2 Cyclin-Dependent Kinase Inhibitors. | |
| 505 | 8 | |a 9.2.3 Proteasome Inhibitors; 9.2.4 PARP Inhibitors; 9.2.5 Various Other Enzyme Inhibitors; References; Chapter 10 Miscellaneous Antineoplastic Agents; 10.1 Acyclic; 10.2 Monocyclic; 10.3 Two Linked Rings; 10.4 Rings on a Chain; 10.4.1 Two Rings; 10.4.2 Four and More Rings; 10.5 Fused Rings; 10.5.1 Indoles; 10.5.2 Purine-Like; 10.5.3 Tetralins and a Naphthalene; 10.5.4 Etc.; References; Appendix A; Index of Heterocycle Syntheses; Subject Index; EULA. | |
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Antineoplastic agents. | |
| 650 | 0 | |a Drugs |x Synthesis. | |
| 650 | 1 | 2 | |a Antineoplastic Agents |x chemical synthesis |
| 650 | 6 | |a Anticancéreux. | |
| 650 | 6 | |a Médicaments |x Synthèse. | |
| 650 | 7 | |a SCIENCE |x Life Sciences |x Biochemistry. |2 bisacsh | |
| 650 | 7 | |a Antineoplastic agents |2 fast | |
| 650 | 7 | |a Drugs |x Synthesis |2 fast | |
| 655 | 4 | |a Internet Resources. | |
| 758 | |i has work: |a Antineoplastic drugs (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGqWc6wmwCVgwY6FQf9Wwy |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Lednicer, Daniel, 1929- |t Antineoplastic drugs. |d Chichester, West Sussex : Wiley, 2015 |z 9781118892541 |w (DLC) 2015008084 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1964101 |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH28397259 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH28335682 | ||
| 938 | |a Baker and Taylor |b BTCP |n BK0016346929 | ||
| 938 | |a Coutts Information Services |b COUT |n 31089705 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL1964101 | ||
| 938 | |a ebrary |b EBRY |n ebr11032414 | ||
| 938 | |a EBSCOhost |b EBSC |n 966490 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n cis31089705 | ||
| 938 | |a Recorded Books, LLC |b RECE |n rbeEB00607377 | ||
| 938 | |a YBP Library Services |b YANK |n 11419803 | ||
| 938 | |a YBP Library Services |b YANK |n 12340685 | ||
| 938 | |a YBP Library Services |b YANK |n 12673559 | ||
| 994 | |a 92 |b IZTAP | ||